Evidence mapPaperPMID 39409015Full record

ArticleInternational journal of molecular sciences2024

SILAC-Based Characterization of Plasma-Derived Extracellular Vesicles in Patients Undergoing Partial Hepatectomy.

Ulrike Resch, Hubert Hackl, David Pereyra, Jonas Santol, Laura Brunnthaler, Joel Probst, Anna Sofie Jankoschek, Monika Aiad, Hendrik Nolte, Marcus Krueger and 2 more

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Article
  3. Special Issue: Characterization of Extracellular Vesicles in Disease.International journal of molecular sciences · 2025
    Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ulrike ReschDepartment of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, A-1090 Vienna, Austria.ORCID 0000-0002-8380-9555
Hubert HacklInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innrain 80, A-6020 Innsbruck, Austria.ORCID 0000-0003-4055-3841
David PereyraDepartment of Surgery, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.ORCID 0000-0001-6700-9163
Jonas SantolDepartment of Surgery, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
Laura BrunnthalerDepartment of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, A-1090 Vienna, Austria.
Joel ProbstDepartment of Surgery, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
Anna Sofie JankoschekDepartment of Surgery, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
Monika AiadDepartment of Surgery, General Hospital, Medical University of Vienna, Währinger Gürtel 18-20, A-1090 Vienna, Austria.
Hendrik NolteCluster of Excellence/Cellular Stress Responses in Aging/Associated Diseases (CECAD), Proteomics Core Facilities, University of Cologne, Joseph-Stelzmann Strasse 26, D-50931 Cologne, Germany.
Marcus KruegerCluster of Excellence/Cellular Stress Responses in Aging/Associated Diseases (CECAD), Proteomics Core Facilities, University of Cologne, Joseph-Stelzmann Strasse 26, D-50931 Cologne, Germany.
Patrick StarlingerInstitute of Bioinformatics, Biocenter, Medical University of Innsbruck, Innrain 80, A-6020 Innsbruck, Austria.
Alice AssingerDepartment of Vascular Biology and Thrombosis Research, Centre of Physiology and Pharmacology, Medical University of Vienna, Schwarzspanierstrasse 17, A-1090 Vienna, Austria.ORCID 0000-0002-5670-5910

Funding

FWF Austrian Science Fund P-32064, P-34783NIDDK NIH HHS R01 DK122813NIH HHS R01DK122813
6 · The paper itself

Abstract

Post-hepatectomy liver failure (PHLF) remains a significant risk for patients undergoing partial hepatectomy (PHx). Reliable prognostic markers and treatments to enhance liver regeneration are lacking. Plasma nanoparticles, including lipoproteins, exosomes, and extracellular vesicles (EVs), can reflect systemic and tissue-wide proteostasis and stress, potentially aiding liver regeneration. However, their role in PHLF is still unknown.

methodsOur study included nine patients with hepatocellular carcinoma (HCC) undergoing PHx: three patients with PHLF, three patients undergoing the associating liver partition and portal vein ligation for staged hepatectomy (ALPPS) procedure, and three matched controls without complications after PHx. Patient plasma was collected before PHx as well as 1 and 5 days after. EVs were isolated by ultracentrifugation, and extracted proteins were subjected to quantitative mass spectrometry using a super-SILAC mix prepared from primary and cancer cell lines.

resultsWe identified 2625 and quantified 2570 proteins in the EVs of PHx patients. Among these, 53 proteins were significantly upregulated and 32 were downregulated in patients with PHLF compared to those without PHLF. Furthermore, 110 proteins were upregulated and 78 were downregulated in PHLF patients compared to those undergoing ALPPS. The EV proteomic signature in PHLF indicates significant disruptions in protein translation, proteostasis, and intracellular vesicle biogenesis, as well as alterations in proteins involved in extracellular matrix (ECM) remodelling and the metabolic and cell cycle pathways, already present before PHx.

conclusionsLongitudinal proteomic analysis of the EVs circulating in the plasma of human patients undergoing PHx uncovers proteomic signatures associated with PHLF, which reflect dying hepatocytes and endothelial cells and were already present before PHx.

Indexed as

Carcinoma, HepatocellularExtracellular VesiclesHepatectomyLiver NeoplasmsProteomicsAgedFemaleHumansLiver FailureMaleMiddle AgedProteomeProteomeextracellular vesiclesliver regenerationpost-hepatectomy liver failureproteomics

Identifiers

PMID39409015
PMCPMC11476990

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.